A DESIGN FOR PHASE-II TESTING OF ANTICANCER AGENTS WITHIN A PHASE-III CLINICAL-TRIAL

被引:18
作者
SCHAID, DJ [1 ]
INGLE, JN [1 ]
WIEAND, S [1 ]
AHMANN, DL [1 ]
机构
[1] MAYO CLIN & MAYO FDN,DIV MED ONCOL,ROCHESTER,MN 55905
来源
CONTROLLED CLINICAL TRIALS | 1988年 / 9卷 / 02期
关键词
D O I
10.1016/0197-2456(88)90032-3
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:107 / 118
页数:12
相关论文
共 20 条
[1]  
AHMANN DL, 1974, CANCER CHEMOTH REP 1, V58, P877
[2]  
AHMANN DL, 1972, CANC CHEMOTHER REP, V3, P29
[3]  
AHMANN DL, 1974, CANCER RES, V34, P27
[4]  
AHMANN DL, 1973, CANCER RES, V33, P1707
[5]  
AHMANN DL, 1974, CANCER CHEMOTH REP 1, V58, P861
[6]   THE EFFECT ON SURVIVAL OF INITIAL CHEMOTHERAPY IN ADVANCED BREAST-CANCER - POLYCHEMOTHERAPY VERSUS SINGLE DRUG [J].
AHMANN, DL ;
SCHAID, DJ ;
BISEL, HF ;
HAHN, RG ;
EDMONSON, JH ;
INGLE, JN .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (12) :1928-1932
[7]  
CARTER SK, 1984, CANCER CLIN TRIALS M
[8]   DESIGNS FOR GROUP SEQUENTIAL PHASE-II CLINICAL-TRIALS [J].
CHANG, MN ;
THERNEAU, TM ;
WIEAND, HS ;
CHA, SS .
BIOMETRICS, 1987, 43 (04) :865-874
[9]   ONE-SAMPLE MULTIPLE TESTING PROCEDURE FOR PHASE-II CLINICAL-TRIALS [J].
FLEMING, TR .
BIOMETRICS, 1982, 38 (01) :143-151
[10]   CALIBRATED PHASE-II CLINICAL-TRIALS IN ONCOLOGY [J].
HERSON, J ;
CARTER, SK .
STATISTICS IN MEDICINE, 1986, 5 (05) :441-447